 |
Doxorubicin HCl with pluronic L-61 and pluronic F-127 |
|---|---|
| Trade Name | |
| Orphan Indication | Esophageal carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2005-10-07 00:00:00 |
| Sponsor | Supratek Pharma Inc.;6100 Royalmount Avenue, Montreal;Quebec H4P 2R2 |
| |
Doxorubicin HCl with pluronic L-61 and pluronic F-127 |
|---|---|
| Trade Name | |
| Orphan Indication | Esophageal carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2005-10-07 00:00:00 |
| Sponsor | Supratek Pharma Inc.;6100 Royalmount Avenue, Montreal;Quebec H4P 2R2 |